Because of the various placings which have occurred since we touched 32p after the Avion partnership announcement I don’t think it will be possible to reach that Sp on the back of a positive FDA meeting on the P3 ....
32p with the dilution since = circa 18p today by my calculations ...
I am not an expert on Bollinger bands but I don’t think I will take classes from you if you don’t know anything about diverging bands and breakouts ...
I think Avion will be pushing like all the others to change the primary endpoint away from Sledai or Bicla ..( Lupus patients want LLDAS to be a primary endpoint ) Trying to get people off steroids is the way forward IMO ....
Sorry but it was YOU who trolled here ...I Just was not at all convinced with the Trial protocol and so preached a cautious viewpoint whilst others were buying castles and Aston martins with their future 10 bagger .... hmmm
I could ask the most beautiful woman in the world to come to my hotel room for a nightcap .... There is a very very very slight chance that she would agree but the probability is that she would decline ..... Avion asking the FDA is in the same category , IMO :-)